Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 166
Filter
Add more filters










Publication year range
1.
Molecules ; 29(9)2024 Apr 26.
Article in English | MEDLINE | ID: mdl-38731476

ABSTRACT

Although the wide variety of bioactivities of curcumin has been reported by researchers, the clinical application of curcumin is still limited due to its poor aqueous solubility. In view of this, a series of dimethylaminomethyl-substituted curcumin derivatives were designed and synthesized (compounds 1-15). Acetate of these derivatives were prepared (compounds 1a-15a). The Mannich reaction and aldol condensation reaction are the main reactions involved in this study. Compounds 6, 10, 12, 3a, 5a, 6a, 7a, 8a, 10a, 11a, 12a, 13a, 14a, and 15a exhibited better in vitro anti-inflammatory activity compared to curcumin in the RAW264.7 cell line. Compounds 5, 1a, 5a, 8a, and 12a exhibited better in vitro antioxidant activity compared to curcumin in the PC 12 cell line. Compounds 11, 13, 5a, 7a, and 13a exhibited better in vitro radiation protection compared to curcumin in the PC 12 cell line. The aqueous solubilities of all the curcumin derivative acetates were greatly improved compared to curcumin.


Subject(s)
Anti-Inflammatory Agents , Antioxidants , Curcumin , Radiation-Protective Agents , Solubility , Curcumin/pharmacology , Curcumin/chemistry , Curcumin/chemical synthesis , Curcumin/analogs & derivatives , Animals , Mice , Antioxidants/pharmacology , Antioxidants/chemistry , Antioxidants/chemical synthesis , RAW 264.7 Cells , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/chemical synthesis , Radiation-Protective Agents/pharmacology , Radiation-Protective Agents/chemical synthesis , Radiation-Protective Agents/chemistry , Drug Design , Structure-Activity Relationship , Molecular Structure , PC12 Cells , Rats , Water/chemistry
2.
Int J Biol Macromol ; 191: 540-547, 2021 Nov 30.
Article in English | MEDLINE | ID: mdl-34571121

ABSTRACT

Biodegradable poly (lactide) (PLA) and poly (butylene adipate-co-terephthalate) (PBAT) composite films were made by a co-precipitation and hot-pressing method. The property of composite films like the chemical interaction, phase morphology, mechanical properties, and thermal properties were studied. The Fourier transform infrared spectroscopy (FTIR) test manifested that there was a small amount of the transesterifications between the PBAT and PLA during hot pressing, which could improve the compatibility of the two phases. The tensile strength of the film only reduced by 7.4%, while the elongation at break was increased by 119.1% compared with PLA after adding 4%wt PBAT. The composite films showed a high Ultraviolet-visible (UV) light barrier property. The UV blocking rate of the composite after adding 4%wt PBAT was 6.95 times higher than that of pure PLA at 380 nm. The PLA/PBAT composite films with excellent thermal stability, satisfactory mechanical properties and UV-light barrier have high a possibility for an UV screening packaging application.


Subject(s)
Biodegradable Plastics/chemical synthesis , Polyesters/chemistry , Radiation-Protective Agents/chemical synthesis , Esterification , Ultraviolet Rays
3.
Carbohydr Polym ; 273: 118619, 2021 Dec 01.
Article in English | MEDLINE | ID: mdl-34561015

ABSTRACT

Rosmarinic acid is an attractive candidate for skin applications because of its antioxidant, anti-inflammatory, and photoprotective functions, however, its poor bioavailability hampers its therapeutic outcome. In this context, synthesis of polymer conjugates is an alternative to enlarge its applications. This work describes the synthesis of novel water-soluble chitosan - rosmarinic acid conjugates (CSRA) that have great potential for skin applications. Chitosan was functionalized with different contents of rosmarinic acid as confirmed by ATR-FTIR, 1H NMR and UV spectroscopies. CSRA conjugates presented three-fold radical scavenger capacity compared to the free phenolic compound. Films were prepared by solvent-casting procedure and the biological activity of the lixiviates was studied in vitro. Results revealed that lixiviates reduced activation of inflamed macrophages, improved antibacterial capacity against E. coli with respect to native chitosan and free rosmarinic acid, and also attenuated UVB-induced cellular damage and reactive oxygen species production in fibroblasts and keratinocytes.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Chitosan/pharmacology , Cinnamates/pharmacology , Depsides/pharmacology , Free Radical Scavengers/pharmacology , Radiation-Protective Agents/pharmacology , Animals , Anti-Inflammatory Agents/chemical synthesis , Anti-Inflammatory Agents/toxicity , Chitosan/analogs & derivatives , Chitosan/toxicity , Cinnamates/chemical synthesis , Cinnamates/toxicity , Depsides/chemical synthesis , Depsides/toxicity , Escherichia coli/drug effects , Fibroblasts/drug effects , Free Radical Scavengers/chemical synthesis , Free Radical Scavengers/toxicity , Humans , Mice , Microbial Sensitivity Tests , Nitric Oxide/metabolism , RAW 264.7 Cells , Radiation-Protective Agents/chemical synthesis , Radiation-Protective Agents/toxicity , Staphylococcus epidermidis/drug effects , Rosmarinic Acid
4.
J Mater Chem B ; 9(15): 3346-3356, 2021 04 21.
Article in English | MEDLINE | ID: mdl-33881426

ABSTRACT

Prostate cancer is one of the leading causes of cancer incidence among males worldwide. Radiotherapy can achieve similar oncological outcomes to those of radical prostatectomy. One concern is, however, radiation damage to the rectum because of the extreme proximity between the two organs. Inserting a biomaterial to separate the prostate and rectum is a promising strategy, and an injectable hydrogel is regarded to be the preferred spacer after screening of various materials. Nevertheless, there exist shortcomings for the currently available injectable hydrogel that cannot fully meet the unique requirements in clinical practice. In this work, a novel injectable hydrogel spacer based on carboxymethyl chitosan (CMC), aldehyde guar gum (AG), and aldehyde iohexol (DHQ) with an imaging function is fabricated. Contrast agent DHQ is chemically attached to CMC-AG network to form a double-crosslinking network to obtain a controlled degradation rate and high strength as well as durable CT imaging function. The hydrogel is injected subcutaneously into rats, where rapid gelation occurs and it serves as a hydrogel spacer. During the month-long in vivo studies, the spacer exhibits remarkable radiation dose attenuation and sustainable imaging function, as well as excellent toxicity profiles. This novel hydrogel shows excellent potential in the protection of critical organs during prostate cancer radiotherapy.


Subject(s)
Contrast Media/chemistry , Cross-Linking Reagents/chemistry , Hydrogels/chemistry , Prostatic Neoplasms/diagnostic imaging , Radiation-Protective Agents/chemistry , Animals , Contrast Media/chemical synthesis , Cross-Linking Reagents/chemical synthesis , Hydrogels/chemical synthesis , Male , Molecular Structure , Radiation-Protective Agents/chemical synthesis , Rats , Rats, Sprague-Dawley , Tomography, X-Ray Computed
5.
Cell Death Dis ; 12(2): 195, 2021 02 18.
Article in English | MEDLINE | ID: mdl-33602915

ABSTRACT

Amifostine has been the only small molecule radio-protector approved by FDA for decades; however, the serious adverse effects limit its clinical use. To address the toxicity issues and maintain the good potency, a series of modified small polycysteine peptides had been prepared. Among them, compound 5 exhibited the highest radio-protective efficacy, the same as amifostine, but much better safety profile. To confirm the correlation between the radiation-protective efficacy and the DNA binding capability, each of the enantiomers of the polycysteine peptides had been prepared. As a result, the L-configuration compounds had obviously higher efficacy than the corresponding D-configuration enantiomers; among them, compound 5 showed the highest DNA binding capability and radiation-protective efficacy. To our knowledge, this is the first study that has proved their correlations using direct comparison. Further exploration of the mechanism revealed that the ionizing radiation (IR) triggered ferroptosis inhibition by compound 5 could be one of the pathways for the protection effect, which was different from amifostine. In summary, the preliminary result showed that compound 5, a polycysteine as a new type of radio-protector, had been developed with good efficacy and safety profile. Further study of the compound for potential use is ongoing.


Subject(s)
Ferroptosis/drug effects , Hematopoietic Stem Cells/drug effects , Intestinal Mucosa/drug effects , Jejunum/drug effects , Lung/drug effects , Peptides/pharmacology , Radiation Injuries/prevention & control , Radiation-Protective Agents/pharmacology , Amifostine/pharmacology , Animals , Cell Line , DNA/metabolism , Disease Models, Animal , Ferroptosis/radiation effects , Glutathione/metabolism , Hematopoietic Stem Cells/metabolism , Hematopoietic Stem Cells/pathology , Hematopoietic Stem Cells/radiation effects , Intestinal Mucosa/metabolism , Intestinal Mucosa/pathology , Intestinal Mucosa/radiation effects , Jejunum/metabolism , Jejunum/pathology , Jejunum/radiation effects , Lipid Peroxidation/drug effects , Lung/metabolism , Lung/pathology , Lung/radiation effects , Male , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Nude , Oxidative Stress/drug effects , Peptides/chemical synthesis , Peptides/metabolism , Radiation Dosage , Radiation Injuries/genetics , Radiation Injuries/metabolism , Radiation Injuries/pathology , Radiation-Protective Agents/chemical synthesis , Radiation-Protective Agents/metabolism , Rats , Whole-Body Irradiation
6.
Biochim Biophys Acta Gen Subj ; 1865(1): 129768, 2021 01.
Article in English | MEDLINE | ID: mdl-33148501

ABSTRACT

BACKGROUND: Extensive research is being carried out globally to design and develop new selenium compounds for various biological applications such as antioxidants, radio-protectors, anti-carcinogenic agents, biocides, etc. In this pursuit, 3,3'-diselenodipropionic acid (DSePA), a synthetic organoselenium compound, has received considerable attention for its biological activities. SCOPE OF REVIEW: This review intends to give a comprehensive account of research on DSePA so as to facilitate further research activities on this organoselenium compound and to realize its full potential in different areas of biological and pharmacological sciences. MAJOR CONCLUSIONS: It is an interesting diselenide structurally related to selenocystine. It shows moderate glutathione peroxidase (GPx)-like activity and is an excellent scavenger of reactive oxygen species (ROS). Exposure to radiation, as envisaged during radiation therapy, has been associated with normal tissue side effects and also with the decrease in selenium levels in the body. In vitro and in vivo evaluation of DSePA has confirmed its ability to reduce radiation induced side effects into normal tissues. Administration of DSePA through intraperitoneal (IP) or oral route to mice in a dose range of 2 to 2.5 mg/kg body weight has shown survival advantage against whole body irradiation and a significant protection to lung tissue against thoracic irradiation. Pharmacokinetic profiling of DSePA suggests its maximum absorption in the lung. GENERAL SIGNIFICANCE: Research work on DSePA reported in fifteen years or so indicates that it is a promising multifunctional organoselenium compound exhibiting many important activities of biological relevance apart from radioprotection.


Subject(s)
Antioxidants/pharmacology , Propionates/pharmacology , Radiation-Protective Agents/pharmacology , Selenium Compounds/pharmacology , Animals , Antioxidants/chemical synthesis , Antioxidants/pharmacokinetics , Antioxidants/toxicity , Humans , Oxidation-Reduction/drug effects , Propionates/chemical synthesis , Propionates/pharmacokinetics , Propionates/toxicity , Radiation-Protective Agents/chemical synthesis , Radiation-Protective Agents/pharmacokinetics , Radiation-Protective Agents/toxicity , Reactive Oxygen Species/metabolism , S-Nitrosothiols/metabolism , Selenium Compounds/chemical synthesis , Selenium Compounds/pharmacokinetics , Selenium Compounds/toxicity
7.
Nat Commun ; 11(1): 6214, 2020 12 04.
Article in English | MEDLINE | ID: mdl-33277480

ABSTRACT

Radioprotectors for acute injuries caused by large doses of ionizing radiation are vital to national security, public health and future development of humankind. Here, we develop a strategy to explore safe and efficient radioprotectors by combining Hantzsch's reaction, high-throughput methods and polymer chemistry. A water-soluble polymer with low-cytotoxicity and an excellent anti-radiation capability has been achieved. In in vivo experiments, this polymer is even better than amifostine, which is the only approved radioprotector for clinical applications, in effectively protecting zebrafish embryos from fatally large doses of ionizing radiation (80 Gy X-ray). A mechanistic study also reveals that the radioprotective ability of this polymer originates from its ability to efficiently prevent DNA damage due to high doses of radiation. This is an initial attempt to explore polymer radioprotectors via a multi-component reaction. It allows exploiting functional polymers and provides the underlying insights to guide the design of radioprotective polymers.


Subject(s)
Chemistry Techniques, Synthetic/methods , Embryo, Nonmammalian/radiation effects , Fibroblasts/radiation effects , Polymers/chemical synthesis , Radiation-Protective Agents/chemical synthesis , X-Rays , Amifostine/pharmacology , Animals , Cell Line , Cell Survival/drug effects , Cell Survival/radiation effects , Comet Assay , DNA Damage/drug effects , DNA Damage/radiation effects , Embryo, Nonmammalian/drug effects , Embryo, Nonmammalian/embryology , Fibroblasts/cytology , Fibroblasts/drug effects , Mice , Models, Chemical , Molecular Structure , Polymers/chemistry , Polymers/pharmacology , Radiation-Protective Agents/chemistry , Radiation-Protective Agents/pharmacology , Zebrafish/embryology
8.
Int J Radiat Biol ; 96(11): 1423-1434, 2020 11.
Article in English | MEDLINE | ID: mdl-32813583

ABSTRACT

PURPOSE: Quinoline is formed by various natural compounds, such as alkaloids from the cinchona plant, which exhibit various biological activities, and is an important building material for the development of new drugs. Quinoline can be used in anti-radiation drug development but radiation interaction properties must be determined. MATERIAL AND METHODS: In this study, six types of synthesized quinoline derivatives were used. Fast neutron removal cross-section, mean free path, half value layer and transmission number were theoretically determined by using GEometry ANd Tracking 4 and FLUktuierende KAskade simulation codes for neutron shielding. Neutron dose absorption rates were determined using the 241Am-Be fast neutron source and the Canberra NP series portable BF3 gas proportional neutron detector. Gamma radiation shielding parameters were determined by using WinXCom and PSY-X/PSD software. Additionally, the genotoxic potentials of the derivatives were assessed by using the Ames/Salmonella bacterial reversion assay. RESULTS AND CONCLUSIONS: Neutron shielding parameters such as removal cross-section, mean free path, half value layer and transmission number were theoretically determined for fast neutrons. To determine neutron absorption capacity of quinoline derivatives, neutron absorption, experiments were conducted. In addition, gamma radiation shielding parameters were calculated such as the mean free path (MFP), mass attenuation coefficient (µt), half value thickness layer (HVL) and effective atomic number (Zeff) in the energy range of 0.015-15 MeV. The results of the all quinoline derivatives have excellent fast neutron shielding power compared to ordinary concrete. In addition, all quinoline derivatives have been found to have the capacity to attenuate gamma radiation. Moreover, they absorb well in both types of radiation, do not cause secondary radiation, and they are genotoxically safe at the tested concentrations. This study has demonstrated that these products can be used as active ingredients for a drug to be developed against radiation.


Subject(s)
Gamma Rays/adverse effects , Neutrons/adverse effects , Quinolines/chemistry , Quinolines/pharmacology , Radiation-Protective Agents/chemistry , Radiation-Protective Agents/pharmacology , Quinolines/chemical synthesis , Radiation-Protective Agents/chemical synthesis
9.
Eur J Med Chem ; 197: 112333, 2020 Jul 01.
Article in English | MEDLINE | ID: mdl-32361176

ABSTRACT

In order to discover new antioxidants, fifteen novel quinazolinone derivatives bearing benzenesulfonamide moiety with variable heterocyclic tail, were synthesized and their structures were established on the basis of spectral data. All the synthesized compounds were screened for their antioxidant potential using DPPH assay in comparison to ascorbic acid. The N-(pyrazin-2-yl)-2-[(4-oxo-3-(4-sulfamoylphenyl)-3,4-dihydroquinazolin-2-yl)thio]acetamide 16 was the most active scaffold in this series with greater scavenging activity than that of ascorbic acid. In vivo acute toxicity study of compound 16 indicates its relative safety with a median lethal dose of 200 mg/kg. The possible antioxidant and hepatoprotective activities of compound 16 were evaluated in irradiated mice. Compound 16 caused mitigation of gamma radiation-induced oxidative stress verified by the decline in MDA, ROS and NF-κB levels. Moreover, SOD and PON1 activities, as well as Zn2+ levels, were improved in liver tissues. Furthermore, molecular docking of compound 16 inside the active site of SOD and PON1 demonstrated the same binding interactions as that of the co-crystallized ligands considering the binding possibilities and energy scores. These findings support that compound 16 may represent a structural lead for developing new antioxidants and hepatoprotective agents.


Subject(s)
Free Radical Scavengers/pharmacology , Liver/drug effects , Quinazolinones/pharmacology , Radiation-Protective Agents/pharmacology , Signal Transduction/drug effects , Sulfonamides/pharmacology , Animals , Aryldialkylphosphatase/chemistry , Aryldialkylphosphatase/metabolism , Catalytic Domain , Free Radical Scavengers/chemical synthesis , Male , Mice , Molecular Docking Simulation , Molecular Structure , NF-kappa B p50 Subunit/metabolism , Oxidative Stress/drug effects , Protein Binding , Quinazolinones/chemical synthesis , Radiation-Protective Agents/chemical synthesis , Structure-Activity Relationship , Sulfonamides/chemical synthesis , Superoxide Dismutase/chemistry , Superoxide Dismutase/metabolism
10.
Eur J Med Chem ; 187: 111606, 2020 Feb 01.
Article in English | MEDLINE | ID: mdl-31901334

ABSTRACT

The goal of this study was to develop novel radioprotective agents targeting the intrinsic apoptotic pathway and thus decreasing the radiation-induced damage. For that purpose, we designed, synthesized and analyzed ten new compounds based on the 1-(4-(2-hydroxyethyl)piperazin-1-yl)-3-phenoxypropan-2-ol leading structure. The cytotoxicity of the newly synthesized substances was tested in vitro on cell lines derived from different progenitor cells by WST-1 proliferation assay. MTT test was utilized to assess half-maximal inhibitory concentrations and maximum tolerated concentrations of novel compounds in A-549 cells. Screening for radioprotective properties was performed using flow-cytometry in MOLT-4 cells exposed to 60Co ionizing gamma radiation. Selected candidates underwent in vivo testing in C57Bl/6 J mice having a positive impact on their immunological status. In summary, we report here promising compounds with radioprotective effect in vivo.


Subject(s)
Propanols/pharmacology , Radiation-Protective Agents/pharmacology , Small Molecule Libraries/pharmacology , Animals , Apoptosis/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Dose-Response Relationship, Drug , Humans , Mice , Mice, Inbred C57BL , Molecular Docking Simulation , Molecular Structure , Propanols/chemical synthesis , Propanols/chemistry , Radiation-Protective Agents/chemical synthesis , Radiation-Protective Agents/chemistry , Small Molecule Libraries/chemical synthesis , Small Molecule Libraries/chemistry , Structure-Activity Relationship
11.
Nanoscale ; 12(2): 548-557, 2020 Jan 02.
Article in English | MEDLINE | ID: mdl-31793608

ABSTRACT

Hypoxia is known to be a common feature within many types of solid tumors, which is closely related to the limited efficacy of radiotherapy. Meanwhile, due to the non-discriminatory killing effect of both normal and cancer cells during the radiation process, traditional radiosensitizers could bring severe non-negligible side-effects to the whole body. In this work, stable and atomically precise Mn clusters which possess efficient pH-triggered catalytic selective capacity are developed rationally. Mn clusters could efficiently catalyze oxygen production in an acidic tumor microenvironment, while exhibiting strong reducibility and free radical scavenging ability in neutral circumstances. In vivo experiments show that Mn clusters are able to enhance the radiotherapy effect in the mouse model of 4T1 tumors and protect normal tissues from radiation at the same time. Thus, the present work provides a novel dual-functional strategy to enhance radiotherapy-induced tumor treatment by improving tumor oxygenation and protect normal tissues from radiation simultaneously.


Subject(s)
Manganese , Neoplasms/radiotherapy , Radiation-Protective Agents/therapeutic use , Radiation-Sensitizing Agents/therapeutic use , Animals , CHO Cells , Catalysis , Cell Line, Tumor , Cell Survival/radiation effects , Cricetulus , Hydrogen-Ion Concentration , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Mice , Oxidation-Reduction , Radiation-Protective Agents/chemical synthesis , Radiation-Protective Agents/chemistry , Radiation-Sensitizing Agents/chemical synthesis , Radiation-Sensitizing Agents/chemistry , Reactive Oxygen Species/metabolism , Treatment Outcome , Tumor Microenvironment
12.
J Cell Mol Med ; 23(3): 2238-2247, 2019 03.
Article in English | MEDLINE | ID: mdl-30663222

ABSTRACT

Radiation-induced intestinal injury is one of the major side effects in patients receiving radiation therapy. There is no specific treatment for radiation enteritis in the clinic. We designed and synthesized a new compound named XH-105, which is expected to cleave into polyphenol and aminothiol in vivo to mitigate radiation injury. In the following study, we describe the beneficial effects of XH-105 against radiation-induced intestinal injury. C57BL/6J mice were treated by gavage with XH-105 1 hour before total body irradiation (TBI), and the survival rate was monitored. Histological changes were examined, and survival of Lgr5+ intestinal stem cells Ki67+ cells, villi+ enterocytes and lysozymes was determined by immunohistochemistry. DNA damage and cellular apoptosis in intestinal tissue were also evaluated. Compared to vehicle-treated mice after TBI, XH-105 treatment significantly enhanced the survival rate, attenuated structural damage of the small intestine, decreased the apoptotic rate, reduced DNA damage, maintained cell regeneration and promoted crypt proliferation and differentiation. XH-105 also reduced the expression of Bax and p53 in the small intestine. These data suggest that XH-105 is beneficial for the protection of radiation-induced intestinal injury by inhibiting the p53-dependent apoptosis signalling pathway.


Subject(s)
Benzopyrans/pharmacology , Enterocytes/drug effects , Intestine, Small/drug effects , Radiation Injuries, Experimental/prevention & control , Radiation-Protective Agents/pharmacology , Animals , Apoptosis/drug effects , Apoptosis/radiation effects , Benzopyrans/chemical synthesis , Benzopyrans/chemistry , Cell Line , DNA Damage/drug effects , DNA Damage/radiation effects , Enterocytes/metabolism , Intestine, Small/metabolism , Intestine, Small/radiation effects , Kaplan-Meier Estimate , Mice, Inbred C57BL , Radiation Injuries, Experimental/etiology , Radiation Injuries, Experimental/metabolism , Radiation-Protective Agents/chemical synthesis , Radiation-Protective Agents/chemistry , Stem Cells/drug effects , Stem Cells/metabolism , Stem Cells/radiation effects , Tumor Suppressor Protein p53/metabolism , Whole-Body Irradiation/adverse effects , bcl-2-Associated X Protein/metabolism
13.
Biochem Biophys Res Commun ; 508(2): 570-575, 2019 01 08.
Article in English | MEDLINE | ID: mdl-30509486

ABSTRACT

Entolimod (CBLB502) is a flagellin-derived radiation countermeasure currently under clinical trial. Entolimod exerts radioprotective activity by directly interacting with TLR5, an innate immune receptor, using the conserved domains of flagellin. Entolimod was designed to contain an artificially introduced N-terminal region that is not related to drug effects and might trigger unexpected toxic immunogenic reactions in humans. To refine the entolimod drug design, we engineered entolimod into KMRC011 by removing its ancillary region. The TLR5 binding and activating capacities of KMRC011 were assessed through biophysical and cellular analyses. KMRC011 forms an exceptionally stable complex with TLR5 at a 1:1 molar ratio with an equilibrium dissociation constant of ∼100 pM and potently activates TLR5. Moreover, alanine scanning mutagenesis identified the R90 and E114 residues of KMRC011 as a TLR5 activation hotspot. Further comparative analysis demonstrated that KMRC011 binds and activates TLR5 in a mode similar to that of entolimod. Thus, we propose that KMRC011 can be used in place of entolimod as a second-generation radiation countermeasure that shows none of the immunogenic side effects derived from the entolimod ancillary region.


Subject(s)
Drug Design , Peptides/genetics , Protein Engineering/methods , Radiation-Protective Agents/chemical synthesis , Toll-Like Receptor 5/metabolism , Binding Sites , Cell Line , Flagellin/chemistry , Humans , Mutagenesis , Mutant Proteins/metabolism , Mutant Proteins/pharmacology , Peptides/metabolism , Protein Binding , Radiation-Protective Agents/pharmacology , Toll-Like Receptor 5/drug effects
14.
Oxid Med Cell Longev ; 2018: 3920147, 2018.
Article in English | MEDLINE | ID: mdl-30116481

ABSTRACT

BACKGROUND: Radiation-induced intestinal injury is one of the side effects in patients receiving radiotherapy. The aim of the present study was to investigate the protective effect of XH-103 on radiation-induced small intestinal injury and to explore its mechanism. METHODS: C57BL/6N mice were irradiated and treated with XH-103. Firstly, the survival rate of mice exposed to 9.0 Gy and 11.0 Gy total body irradiation (TBI) was examined. Subsequently, at 3.5 d after IR, the small intestinal morphological changes were examined by HE. The numbers of crypt cells, the villus height, the expression of Ki67 and Lgr5, and the apoptotic cells in the intestinal crypts were examined by immunohistochemistry. Furthermore, the expression of p53 and Bax was analyzed by WB. RESULTS: Compared to the irradiation group, XH-103 improved the mice survival rate, protected the intestinal morphology of mice, decreased the apoptotic rate of intestinal crypt cells, maintained cell regeneration, and promoted crypt proliferation and differentiation. XH-103 also reduced the expression of p53 and Bax in the small intestine compared to the IR group. CONCLUSION: These data demonstrate that XH-103 can prevent radiation-induced intestinal injury, which is beneficial for the protection of radiation injuries.


Subject(s)
Benzopyrans/pharmacology , Intestine, Small/drug effects , Intestine, Small/radiation effects , Radiation Injuries, Experimental/drug therapy , Radiation-Protective Agents/pharmacology , Thiazolidines/pharmacology , Animals , Apoptosis/drug effects , Apoptosis/radiation effects , Benzopyrans/chemical synthesis , Benzopyrans/chemistry , DNA Damage , Intestinal Mucosa/drug effects , Intestinal Mucosa/metabolism , Intestinal Mucosa/pathology , Intestinal Mucosa/radiation effects , Intestine, Small/metabolism , Intestine, Small/pathology , Male , Mice , Mice, Inbred C57BL , Radiation Injuries, Experimental/metabolism , Radiation Injuries, Experimental/prevention & control , Radiation-Protective Agents/chemical synthesis , Radiation-Protective Agents/chemistry , Random Allocation , Thiazolidines/chemical synthesis , Thiazolidines/chemistry , Tumor Suppressor Protein p53/metabolism , Whole-Body Irradiation/adverse effects
15.
Radiat Res ; 188(3): 264-275, 2017 09.
Article in English | MEDLINE | ID: mdl-28657498

ABSTRACT

Mitochondrial dysfunction plays an important role in gamma-radiation-induced mediating oxidative stress. Scavenging radiation-induced reactive oxygen species (ROS) can help mitochondria to maintain their physiological function. Rosmarinic acid is a polyphenol antioxidant that can scavenge radiation-induced ROS, but the structure prevents it from accumulating in mitochondria. In this study, we designed and synthesized a novel rosmarinic acid derivative (Mito-RA) that could use the mitochondrial membrane potential to enter the organelle and scavenge ROS. The DCFH-DA assay revealed that Mito-RA was more effective than rosmarinic acid at scavenging ROS. DNA double-strand breaks, chromosomal aberration, micronucleus and comet assays demonstrated the ability of Mito-RA to protect against radiation-induced oxidative stress in vitro. These findings demonstrate the potential of Mito-RA as an antioxidant, which can penetrate mitochondria, scavenge ROS and protect cells against radiation-induced oxidative damage.


Subject(s)
Cinnamates/administration & dosage , DNA Damage/physiology , Depsides/administration & dosage , Mitochondria/physiology , Oxidative Stress/physiology , Radiation-Protective Agents/administration & dosage , Reactive Oxygen Species/metabolism , Animals , Antioxidants/administration & dosage , CHO Cells , Chromosome Aberrations/drug effects , Chromosome Aberrations/radiation effects , Cinnamates/chemical synthesis , Cricetulus , DNA Damage/drug effects , Depsides/chemical synthesis , Dose-Response Relationship, Drug , HeLa Cells , Humans , Membrane Potential, Mitochondrial/drug effects , Membrane Potential, Mitochondrial/physiology , Membrane Potential, Mitochondrial/radiation effects , Mitochondria/drug effects , Mitochondria/ultrastructure , Oxidative Stress/drug effects , Oxidative Stress/radiation effects , Radiation-Protective Agents/chemical synthesis , Subcellular Fractions/drug effects , Subcellular Fractions/metabolism , Subcellular Fractions/radiation effects , Rosmarinic Acid
16.
ChemMedChem ; 12(10): 760-769, 2017 05 22.
Article in English | MEDLINE | ID: mdl-28417557

ABSTRACT

Ultraviolet (UV) light is the most abundant and significant modifiable risk factor for skin cancer and many other skin diseases such as early photo-aging. Across the solar radiation spectrum, UV light is the main cause behind skin problems. In the search for novel photoprotective compounds, a new series of 8-substituted purines were synthesized from commercially available 6-hydroxy-4,5-diaminopyrimidine hemisulfate or 4,5-diaminopyrimidine. All title compounds were investigated for their UV filtering, antioxidant, antifungal, and antiproliferative activities. For the photoprotection assays we used a diffuse transmittance technique to determine the sun protection factor (SPF) in vitro, and 2,2-diphenyl-1-picrylhydrazyl (DPPH) and ferric ion reducing antioxidant power (FRAP) tests for evaluating the antioxidant activity of the more potent compounds. Among them, 8-(2,5-dihydroxyphenyl)-7H-purin-6-ol (compound 26) proved to be a good radical scavenger and is also endowed with broad-spectrum UVA filtering capabilities, suitable for further development as a protective molecule.


Subject(s)
Antifungal Agents/pharmacology , Antineoplastic Agents/pharmacology , Antioxidants/pharmacology , Purines/chemistry , Purines/pharmacology , Radiation-Protective Agents/pharmacology , Ultraviolet Rays/adverse effects , Animals , Antifungal Agents/chemical synthesis , Antifungal Agents/chemistry , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Antioxidants/chemical synthesis , Antioxidants/chemistry , Cell Line, Tumor , Cell Proliferation/drug effects , Dose-Response Relationship, Drug , Drug Screening Assays, Antitumor , Fungi/drug effects , Humans , Mice , Microbial Sensitivity Tests , Molecular Structure , Purines/chemical synthesis , Radiation-Protective Agents/chemical synthesis , Radiation-Protective Agents/chemistry , Structure-Activity Relationship , Sun Protection Factor
17.
J Photochem Photobiol B ; 162: 694-702, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27505300

ABSTRACT

In the present study, novel symmetrical curcumin analogues (2-7) have been synthesized by substituting the phenolic OH of curcumin with different linkers providing additional keto-enol tautomerism, very essential for radioprotective activity. The structures of the synthesized compounds (2-7) were elucidated by elemental analysis, IR, (1)H-NMR, (13)C-NMR and mass spectral data and were found consistent with the assigned structures. The curative effect of these new compounds, against the oxidative stress due to exposure of rats to the whole body γ-irradiation (7Gy) was investigated. Gamma-irradiated rats exhibited elevations of ALT, AST activities, urea, creatinine, triglycerides, total cholesterol, malondialdehyde (MDA), nitric oxide (NO), Interleukin-6 (IL-6), Tumor Necrosis Factor-α (TNF-α) and Nuclear Factor-kappa B (NF-κB) levels. Contrariwise, the total protein, albumin, total calcium level, SOD, CAT, GSH-Px, GST activities and GSH content were decreased. Treatment of gamma-irradiated rats with the new curcumin analogues (2-7) showed significant amelioration in the in-vivo antioxidant status, liver and kidney functions, as well as the anti-inflammatory markers (IL-6, TNF-α and NF-κB). Inhibition of NF-κB could be responsible for the improvement of the antioxidant and anti-inflammatory status in gamma-irradiated animals, by down-regulation of IL-1ß and TNF-α level. In conclusion, the new curcumin analogues (2-7) exhibited post-protective effect on gamma-irradiation, by NF-κB inhibition.


Subject(s)
Curcumin/pharmacology , Down-Regulation/drug effects , Oxidative Stress/drug effects , Radiation-Protective Agents/pharmacology , Animals , Antioxidants/metabolism , Biomarkers/blood , Catalase/metabolism , Cholesterol/blood , Curcumin/analogs & derivatives , Curcumin/chemical synthesis , Down-Regulation/radiation effects , Enzyme-Linked Immunosorbent Assay , Female , Gamma Rays , Glutathione Peroxidase/metabolism , Interleukin-6/blood , Magnetic Resonance Spectroscopy , Malondialdehyde/blood , NF-kappa B/blood , Oxidative Stress/radiation effects , Radiation-Protective Agents/chemical synthesis , Radiation-Protective Agents/chemistry , Rats , Rats, Wistar , Spectrophotometry, Infrared , Superoxide Dismutase/metabolism , Tumor Necrosis Factor-alpha/blood
18.
Bioorg Med Chem Lett ; 26(16): 3886-91, 2016 08 15.
Article in English | MEDLINE | ID: mdl-27426305

ABSTRACT

A facile and rapid access to resveratrol derivatives has been achieved based on palladium-catalyzed oxidative Heck reaction of aryl boronic acids with styrenes followed by demethylation in moderate to good yields. A series of resveratrol derivatives with various functional groups has been synthesized easily. The radioprotective activity of synthesized compounds has also been evaluated using rat thymocytes. The results revealed that some resveratrol derivatives efficiently protected the thymocytes from radiation-induced apoptosis.


Subject(s)
Radiation-Protective Agents/chemistry , Stilbenes/chemistry , Animals , Apoptosis/drug effects , Apoptosis/radiation effects , Boronic Acids/chemistry , Catalysis , Gamma Rays , Oxidation-Reduction , Palladium/chemistry , Radiation-Protective Agents/chemical synthesis , Radiation-Protective Agents/pharmacology , Rats , Resveratrol , Stilbenes/chemical synthesis , Stilbenes/pharmacology , Structure-Activity Relationship , Styrenes/chemistry , Thymocytes/drug effects , Thymocytes/metabolism , Thymocytes/radiation effects
19.
Int J Mol Sci ; 17(6)2016 Jun 14.
Article in English | MEDLINE | ID: mdl-27314327

ABSTRACT

Antioxidants are prospective radioprotectors because of their ability to scavenge radiation-induced reactive oxygen species (ROS). The hematopoietic system is widely studied in radiation research because of its high radiosensitivity. In the present study, we describe the beneficial effects of 5-methoxytryptamine-α-lipoic acid (MLA), which was synthesized from melatonin and α-lipoic acid, against radiation-induced hematopoietic injury. MLA administration significantly enhanced the survival rate of mice after 7.2 Gy total body irradiation. The results showed that MLA not only markedly increased the numbers and clonogenic potential of hematopoietic cells but also decreased DNA damage, as determined by flow cytometric analysis of histone H2AX phosphorylation. In addition, MLA decreased the levels of ROS in hematopoietic cells by inhibiting NOX4 expression. These data demonstrate that MLA prevents radiation-induced hematopoietic syndrome by increasing the number and function of and by inhibiting DNA damage and ROS production in hematopoietic cells. These data suggest MLA is beneficial for the protection of radiation injuries.


Subject(s)
5-Methoxytryptamine/therapeutic use , Acute Radiation Syndrome/drug therapy , Hematopoiesis/drug effects , Radiation-Protective Agents/therapeutic use , Thioctic Acid/analysis , Thioctic Acid/therapeutic use , 5-Methoxytryptamine/chemical synthesis , 5-Methoxytryptamine/chemistry , 5-Methoxytryptamine/pharmacology , Acute Radiation Syndrome/metabolism , Acute Radiation Syndrome/prevention & control , Animals , DNA Damage/drug effects , Histones/metabolism , Male , Melatonin/chemistry , Mice , Mice, Inbred C57BL , NADPH Oxidase 4 , NADPH Oxidases/genetics , NADPH Oxidases/metabolism , Radiation, Ionizing , Radiation-Protective Agents/administration & dosage , Radiation-Protective Agents/chemical synthesis , Radiation-Protective Agents/pharmacology , Reactive Oxygen Species/metabolism , Thioctic Acid/chemical synthesis , Thioctic Acid/chemistry , Thioctic Acid/pharmacology
20.
Int J Biol Macromol ; 83: 426-32, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26546870

ABSTRACT

Herein we represent a new discovery based on amine material called hexamethyltriethylene tetramine (HMTETA). We have observed that when an aqueous solution of Zn(NO3)·6H2O was added to aqueous solution of HMTETA followed by shaking for a time, the colorless solution was converted to milky color under the alkaline medium provided by HMTETA prior to formation of uniform zinc oxide nanoparticles (ZnO NPs). The latter are in situ formed within the cotton fabrics without the support of capping or other stabilizing agents. Obviously, then, the new made of formation of ZnO NPs speaks of a single-stage process where cotton fabric is immersed in a prepared solution of the new precursors through which binding of ZnO NPs into the textile fabrics takes place. Textile fabrics are, indeed, used as a template, which is capable of maintaining the size and surface distribution of the as-synthesized nanoparticles in a uniform domain. It is also likely that nanoparticles is confined inside the fibril and microfibrils of the cotton fibers. World-class facilities have been employed to follow up the synthesis of ZnO NPs, their characterization and their application to confer, in particular, high durable antibacterial and UV protective function on cotton fabrics.


Subject(s)
Cotton Fiber , Nanoparticles , Radiation-Protective Agents/chemistry , Radiation-Protective Agents/pharmacology , Ultraviolet Rays/adverse effects , Zinc Oxide/chemistry , Zinc Oxide/pharmacology , Bridged-Ring Compounds/chemistry , Chemistry Techniques, Synthetic , Laundering , Mechanical Phenomena , Radiation-Protective Agents/chemical synthesis , Staphylococcus aureus/drug effects , Water/chemistry , Zinc Oxide/chemical synthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...